Cutler Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-782
Closed -$21K 4044
2022
Q4
$21K Buy
782
+453
+138% +$13K ﹤0.01% 2180
2022
Q3
$11K Sell
329
-2,500
-88% -$88.1K ﹤0.01% 3063
2022
Q2
$86K Sell
2,829
-11,000
-80% -$321K 0.01% 1536
2022
Q1
$446K Buy
13,829
+13,772
+24,161% +$361K 0.02% 730
2021
Q4
$1K Hold
57
﹤0.01% 4980
2021
Q3
$1K Hold
57
﹤0.01% 5287
2021
Q2
$1K Buy
+57
New +$1.14K ﹤0.01% 5270
2021
Q1
Sell
-39
Closed -$742 5804
2020
Q4
$0 Hold
39
﹤0.01% 4985
2020
Q3
$0 Buy
+39
New +$459 ﹤0.01% 4819
2020
Q1
Sell
-538
Closed -$4.81K 4174
2019
Q4
$4K Buy
+538
New +$4.37K ﹤0.01% 3134
2019
Q3
Sell
-2,719
Closed -$19.5K 4225
2019
Q2
$21K Sell
2,719
-4,800
-64% -$56.8K ﹤0.01% 2162
2019
Q1
$94K Buy
+7,519
New +$119K 0.01% 1034
2018
Q4
Sell
-870
Closed -$20.1K 4112
2018
Q3
$24K Sell
870
-2,106
-71% -$50.2K ﹤0.01% 2118
2018
Q2
$62K Buy
+2,976
New +$56.3K ﹤0.01% 1469
2017
Q4
Sell
-1,276
Closed -$18K 5151
2017
Q3
$22K Sell
1,276
-524
-29% -$10.8K ﹤0.01% 3037
2017
Q2
$45K Sell
1,800
-1,209
-40% -$29.1K ﹤0.01% 2591
2017
Q1
$67K Buy
+3,009
New +$57.8K ﹤0.01% 2102
2016
Q4
Sell
-17,242
Closed -$340K 6714
2016
Q3
$424K Buy
17,242
+16,942
+5,647% +$396K 0.02% 690
2016
Q2
$5K Sell
300
-891
-75% -$12.2K ﹤0.01% 4907
2016
Q1
$12K Buy
+1,191
New +$12.3K ﹤0.01% 3835

Other funds holding EVH

Cutler Group's EVH Position: Q1 2023 in Review

Cutler Group sold out of Evolent Health (EVH) in Q1 2023, closing a stake of 782 shares — an estimated $21K sold.

Cutler Group first reported a position in EVH in Q1 2016 and held it in 20 quarters. The position peaked at $446K in Q1 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q1 2023.

  • Cutler Group reported no remaining Evolent Health position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 782 Evolent Health shares in Q1 2023, an estimated $21K.
  • Cutler Group first reported a position in Evolent Health in Q1 2016 and held it in 20 quarters.
  • Cutler Group's Evolent Health position peaked at $446K in Q1 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.